Chandy KG[au] - Search Results

Year	Number of Results
1979	1
1980	3
1981	3
1982	1
1983	3
1984	4
1985	5
1986	2
1987	5
1988	3
1989	1
1990	4
1991	1
1992	3
1993	4
1994	2
1996	3
1997	3
1998	9
1999	7
2000	3
2001	8
2002	3
2003	7
2004	6
2005	5
2006	1
2007	10
2008	4
2009	4
2010	1
2011	4
2012	5
2013	4
2014	2
2016	2
2017	7
2018	1
2019	1
2020	3
2021	1

1

Antibodies and venom peptides: new modalities for ion channels.

Wulff H, Christophersen P, Colussi P, Chandy KG, Yarov-Yarovoy V. Wulff H, et al. Among authors: chandy kg. Nat Rev Drug Discov. 2019 May;18(5):339-357. doi: 10.1038/s41573-019-0013-8. Nat Rev Drug Discov. 2019. PMID: 30728472 Free PMC article. Review.

2

Contributions of natural products to ion channel pharmacology.

Bajaj S, Ong ST, Chandy KG. Bajaj S, et al. Among authors: chandy kg. Nat Prod Rep. 2020 May 1;37(5):703-716. doi: 10.1039/c9np00056a. Epub 2020 Feb 17. Nat Prod Rep. 2020. PMID: 32065187 Review.

3

Venom-derived peptide inhibitors of voltage-gated potassium channels.

Norton RS, Chandy KG. Norton RS, et al. Among authors: chandy kg. Neuropharmacology. 2017 Dec;127:124-138. doi: 10.1016/j.neuropharm.2017.07.002. Epub 2017 Jul 5. Neuropharmacology. 2017. PMID: 28689025 Review.

4

Modulation of Lymphocyte Potassium Channel K_V1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin.

Ong ST, Bajaj S, Tanner MR, Chang SC, Krishnarjuna B, Ng XR, Morales RAV, Chen MW, Luo D, Patel D, Yasmin S, Ng JJH, Zhuang Z, Nguyen HM, El Sahili A, Lescar J, Patil R, Charman SA, Robins EG, Goggi JL, Tan PW, Sadasivam P, Ramasamy B, Hartimath SV, Dhawan V, Bednenko J, Colussi P, Wulff H, Pennington MW, Kuyucak S, Norton RS, Beeton C, Chandy KG. Ong ST, et al. Among authors: chandy kg. ACS Pharmacol Transl Sci. 2020 May 14;3(4):720-736. doi: 10.1021/acsptsci.0c00035. eCollection 2020 Aug 14. ACS Pharmacol Transl Sci. 2020. PMID: 32832873 Free PMC article.

5

Ion channels in lymphocytes.

Chandy KG, DeCoursey TE, Cahalan MD, Gupta S. Chandy KG, et al. J Clin Immunol. 1985 Jan;5(1):1-6. doi: 10.1007/BF00915161. J Clin Immunol. 1985. PMID: 2579969 Review.

6

Peptide blockers of K_v1.3 channels in T cells as therapeutics for autoimmune disease.

Chandy KG, Norton RS. Chandy KG, et al. Curr Opin Chem Biol. 2017 Jun;38:97-107. doi: 10.1016/j.cbpa.2017.02.015. Epub 2017 Apr 14. Curr Opin Chem Biol. 2017. PMID: 28412597 Review.

7

Therapeutic potential of peptide toxins that target ion channels.

Beraud E, Chandy KG. Beraud E, et al. Among authors: chandy kg. Inflamm Allergy Drug Targets. 2011 Oct;10(5):322-42. doi: 10.2174/187152811797200696. Inflamm Allergy Drug Targets. 2011. PMID: 21745182 Review.

8

International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels.

Kaczmarek LK, Aldrich RW, Chandy KG, Grissmer S, Wei AD, Wulff H. Kaczmarek LK, et al. Among authors: chandy kg. Pharmacol Rev. 2017 Jan;69(1):1-11. doi: 10.1124/pr.116.012864. Epub 2016 Nov 15. Pharmacol Rev. 2017. PMID: 28267675 Review.

9

Potassium channels, memory T cells, and multiple sclerosis.

Beeton C, Chandy KG. Beeton C, et al. Among authors: chandy kg. Neuroscientist. 2005 Dec;11(6):550-62. doi: 10.1177/1073858405278016. Neuroscientist. 2005. PMID: 16282596 Review.

10

Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Chi V, Pennington MW, Norton RS, Tarcha EJ, Londono LM, Sims-Fahey B, Upadhyay SK, Lakey JT, Iadonato S, Wulff H, Beeton C, Chandy KG. Chi V, et al. Among authors: chandy kg. Toxicon. 2012 Mar 15;59(4):529-46. doi: 10.1016/j.toxicon.2011.07.016. Epub 2011 Aug 12. Toxicon. 2012. PMID: 21867724 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results